Moyamoya Disease Market Size is estimated to grow at a CAGR of 5.8% during the forecast period
The Moyamoya disease market was estimated to be worth USD 895.4 million in 2022, and over the course of the forecast period, a CAGR of 5.8% is anticipated. MRIs, CT scans, PET scans, and cerebral angiograms are all part of this diagnostic market. A genetic abnormality is the cause of this sickness. Growing consumer awareness of Moyamoya disease diagnostics is propelling the market's expansion. It is a type of cerebrovascular illness that was initially identified in Japan. The term "puff of smoke" in Japanese refers to the appearance of little vessels that make up for obstructions. The market is expanding as a result of the disease's rising incidence among Asian populations. Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/moyamoya-disease-market Growth Drivers The market is expanding due to rising public awareness of neurological illnesses, advancements in medical diagnosis technology, increased research and developme...